降钙素原(PCT)急诊临床应用的专家共识(11)
[95]Ittner L， Born W， Rau B， et al. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma[J]. Eur J Endocrinol， 2002，147(6)：727—731.
[96]Becker KL， Gazdar AF， Carney DN， et al. Calcitonin secretion by continuous cultures of small cell carcinoma of the lung： incidence and immunoheterogeneity studies[J]. Cancer Lett， 1983，18(2)：179—185.
[97]Algeciras—Schimnich A， Preissner CM， Theobald JP， et al. Procal—citonin： a marker for the diagnosis and follow—up of patients with medullary thyroid carcinoma[J]. J Clin Endocrinol Metab， 2009，94(3)：861—868.
, 百拇医药
[98]Matzaraki V， Alexandraki KI， Venetsanou K， et al. Evaluation of serum procalcitonin and interleukin—6 levels as markers of liver metastasis[J]. Clin Biochem， 2007，40(5/6)：336—342.
[99]Ciaccio M， Fugardi G， Titone L， et al. Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections[J]. Clin Chim Acta， 2004，340(1/2)：149—152.
[100]Fleischhack G， Kambeck I， Cipic D， et al. Procalcitonin in paediatric cancer patients： its diagnostic relevance is superior to that of C—reactive protein， interleukin 6， interleukin 8， soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II[J]. Br J Haematol， 2000，111(4)：1093—1102.
, 百拇医药
[101]Fleischhack G， Cipic D， Juettner J， et al. Procalcitonin—a sensitive inflammation marker of febrile episodes in neutropenic children with cancer[J]. Intensive Care Med， 2000， 26 Suppl 2：S202—211.
[102]von Lilienfeld—Toal M， Dietrich MP， Glasmacher A， et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies： procalcitonin and IL—6 are more reliable than C—reactive protein[J]. Eur J Clin Microbiol Infect Dis， 2004，23(7)：539—544.
, http://www.100md.com
[103]Hatzistilianou M， Rekleity A， Athanassiadou F， et al. Serial procalcitonin responses in infection of children with secondary immunodeficiency[J]. Clin Invest Med， 2007，30(2)：E75—85.
[104]Rinaldi S， Adembri C， Grechi S， et al. Low—dose hydrocortisone during severe sepsis： effects on microalbuminuria[J]. Crit Care Med， 2006，34(9)：2334—2339.
[105]al—Nawas B， Shah PM.Procalcitonin in patients with and without immunosuppression and sepsis[J]. Infection， 1996，24(6)：434—436.
, http://www.100md.com
[106]Engel A， Steinbach G， Kern P， et al. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever： comparison with interleukin—8[J]. Scand J Infect Dis， 1999，31(2)：185—189.
[107]Bernard L， Ferrière F， Casassus P， et al. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults[J]. Clin Infect Dis， 1998，27(4)：914—915.
, 百拇医药(降钙素原急诊临床应用专家共识组)
[96]Becker KL， Gazdar AF， Carney DN， et al. Calcitonin secretion by continuous cultures of small cell carcinoma of the lung： incidence and immunoheterogeneity studies[J]. Cancer Lett， 1983，18(2)：179—185.
[97]Algeciras—Schimnich A， Preissner CM， Theobald JP， et al. Procal—citonin： a marker for the diagnosis and follow—up of patients with medullary thyroid carcinoma[J]. J Clin Endocrinol Metab， 2009，94(3)：861—868.
, 百拇医药
[98]Matzaraki V， Alexandraki KI， Venetsanou K， et al. Evaluation of serum procalcitonin and interleukin—6 levels as markers of liver metastasis[J]. Clin Biochem， 2007，40(5/6)：336—342.
[99]Ciaccio M， Fugardi G， Titone L， et al. Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections[J]. Clin Chim Acta， 2004，340(1/2)：149—152.
[100]Fleischhack G， Kambeck I， Cipic D， et al. Procalcitonin in paediatric cancer patients： its diagnostic relevance is superior to that of C—reactive protein， interleukin 6， interleukin 8， soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II[J]. Br J Haematol， 2000，111(4)：1093—1102.
, 百拇医药
[101]Fleischhack G， Cipic D， Juettner J， et al. Procalcitonin—a sensitive inflammation marker of febrile episodes in neutropenic children with cancer[J]. Intensive Care Med， 2000， 26 Suppl 2：S202—211.
[102]von Lilienfeld—Toal M， Dietrich MP， Glasmacher A， et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies： procalcitonin and IL—6 are more reliable than C—reactive protein[J]. Eur J Clin Microbiol Infect Dis， 2004，23(7)：539—544.
, http://www.100md.com
[103]Hatzistilianou M， Rekleity A， Athanassiadou F， et al. Serial procalcitonin responses in infection of children with secondary immunodeficiency[J]. Clin Invest Med， 2007，30(2)：E75—85.
[104]Rinaldi S， Adembri C， Grechi S， et al. Low—dose hydrocortisone during severe sepsis： effects on microalbuminuria[J]. Crit Care Med， 2006，34(9)：2334—2339.
[105]al—Nawas B， Shah PM.Procalcitonin in patients with and without immunosuppression and sepsis[J]. Infection， 1996，24(6)：434—436.
, http://www.100md.com
[106]Engel A， Steinbach G， Kern P， et al. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever： comparison with interleukin—8[J]. Scand J Infect Dis， 1999，31(2)：185—189.
[107]Bernard L， Ferrière F， Casassus P， et al. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults[J]. Clin Infect Dis， 1998，27(4)：914—915.
, 百拇医药(降钙素原急诊临床应用专家共识组)